1 The subtype and anatomical localization of P-adrenoceptors mediating facilitation of stimulusinduced overflow of noradrenaline ('prejunctional P-adrenoceptors') are not conclusively known to date.
Introduction
Regulation of sympathetic neurotransmission is achieved at suggested that physiologically, prejunctional P-adrenoceptors various levels in the body. An important regulatory site is the may be activated by neuronally released NA (Adler-Graschsympathetic nerve terminal which is presumably endowed insky & Langer, 1975) . Alternatively, adrenaline may assume with various 'prejunctional' receptors. Activation of these the role of physiological activator for these receptors (Stjarne receptors results in either inhibition or facilitation of exo-& Brundin, 1976) . However, the question of physiological cytotic noradrenaline (NA) release from the nerve terminals.
agonist for prejunctional P-adrenoceptors is intimately related One of the facilitatory receptor systems is the prejunctional to the P-adrenoceptor subtype mediating the facilitatory res-P-adrenoceptor system. ponse because, NA is equipotent with or more potent than Prejunctional P-adrenoceptors enhance stimulus-induced adrenaline at the P,-and P3-subtypes while adrenaline is more (S-I) overflow of NA from sympathetic varicosities. The potent than NA at the p2-subtype (Lands et al., 1967; Bond presence of these receptors has been demonstrated in various & Clarke, 1988) . tissues and species (cf. Misu & Kubo, 1986) . It 
has been
Attempts have been made to characterize prejunctional P-adrenoceptors, but have yielded contradictory results. For example, the involvement of P,-adrenoceptors in the facili-' Author for correspondence.
tatory response was implied in the cat hindlimb (Dahlof et Q Macmillan Press Ltd, 1994 PREJUNCTIONAL P-RECEPTOR SUBTYPES AND LOCALIZATION 1297 , rabbit ear artery (Majewski & Rand, 1981) and rat portal vein (Ortiz de Urbina et al., 1992) . Conversely, P2-adrenoceptors were suggested to mediate the facilitatory response in the human omental artery and vein (Stjarne & Brundin, 1976) , rat mesentery (Kawasaki et al., 1982) and guinea-pig papillary muscle (Valenta & Singer, 1991) . Biological variation between different tissues and species cannot account for these controversial results, as different groups have reported different prejunctional P-adrenoceptor subtypes in the same tissue (Dahlof et al., 1978; Westfall et al., 1979; Remie et al., 1988; Ortiz de Urbina et al., 1992) . Instead, the primary reason for these conflicting results seems to be the use of inadequate methods (such as, using only one or two concentrations of the P-adrenoceptor agents or failing to achieve equilibrium conditions) instead of appropriate pharmacological techniques, to characterize the receptors. Thus, a proper characterization of prejunctional P-adrenoceptors with the aid of suitable pharmacological methods is warranted.
Another controversial issue surrounding peripheral prejunctional 13-adrenoceptors is their anatomical localization. Although these receptors are believed to be present on sympathetic nerve terminals (hence 'prejunctional'), anatomical evidence supporting this concept is sparse to date. The prejunctional localization of these receptors has been reported in a few tissues, such as the rat and cat spleen (Sharma & Banerjee, 1978; Dahlof et al., 1986) , while supportive evidence has been difficult to obtain in other tissues, such as the rat kidney cortex (Fortin & Sundaresan, 1989) . In addition, it has been proposed recently that P-adrenoceptors mediating facilitation of S-I overflow of NA in the rat vena cava may be postjunctionally located and may elicit facilitation by releasing a transjunctional mediator (Gothert & Kollecker, 1986) , thus raising a question regarding the concept of prejunctional localization of 'prejunctional' I3-adrenoceptors. Also, even in tissues where the prejunctional localization of these receptors has been reported (Sharma & Banerjee, 1978; Dahlof et al., 1986 ), the precise anatomical location of the sympathetic varicosities containing these receptors within the tissue has not been examined.
Therefore, the present investigation was undertaken to characterize prejunctional P-adrenoceptors in the rat kidney by use of pharmacological techniques such as pKb determination for antagonists and determination of potency ratio of agonists. The putative prejunctional localization of these receptors also was studied by examining P-adrenoceptor populations in the innervated and surgically denervated preparations by radio-ligand binding and autoradiography.
Methods
Isolated perfused rat kidney preparation Surgical procedure The rat kidney was isolated as described previously (Schwartz & Eikenburg, 1988) . Male Wistar rats (Charles-River, PA, U.S.A.) weighing 250-300 g were anaesthetized with sodium pentobarbitone (60 mg kg-', i.p.). The abdominal cavity was opened by a midline incision and the right kidney, right renal artery, superior mesenteric artery and aorta were located and cleaned of surrounding tissues. Fifteen minutes following heparinization (1500 i.u., i.v.), the superior mesenteric artery was cannulated and then the cannula was advanced further into the renal artery. The right kidney along with the renal artery was isolated from the rat, placed in the perfusion apparatus and perfused (6 ml min-') with carbogenated Krebs bicarbonate solution (pH: 7.4) maintained at 37C. antagonist, phentolamine (10 pM) was added to the perfusate to minimize the influences of prejunctional a-adrenoceptors and S-I perfusion pressure changes on S-I NA overflow.
Captopril (0.1 M) and indomethacin (3 fiM) also were added to the perfusate to inibit renal synthesis of angiotensin II and prostaglandins, respectively. The kidney was allowed to stabilize for an additional 45 min after which 9 consecutive stimulations (S1 to S9) were delivered at 20 min intervals using a Grass stimulator (10 pulses, 1 Hz, 1 ms, supramaximal V). During each stimulation and 1 min following that, the perfusate was collected and analyzed for NA content. At the end, of the experiment, the kidney was weighed and homogenized with 5 ml of 1.0 N HC1O4 and an aliquot of the homogenate supernatant was analyzed for determination of the total renal NA content. The weight of kidney ranged from 1.5 to 2g.
Estimation of NA NA was extracted from the perfusate and homogenate samples by an alumina extraction method (Schwartz & Eikenburg, 1988) and the content in the final eluate was analyzed by reverse phase high pressure liquid chromatography coupled with electrochemical detection (h.p.l.c.-e.c.). The overflow of NA in the absence of stimulations was non-detectable.
Calculation and expression of NA release S-I release of NA has been expressed as absolute and fractional overflows. These terms were calculated using the following formulae: Stimulus-induced overflow (pmol) Absolute overflow (pmol g-')=
Iinywihg
Kidney weight (g)
Fractional overflow (%)= Absolute overflow (pmol g-')
x 100
Renal NA content at the time of stimulation (pmol g-') When a stimulation was performed in the presence of a Construction of agonist concentration-response curve On the basis of preliminary experiments, an appropriate agonist concentration-range (over which the responses are concentration-dependent) was chosen and 6 to 7 concentrations of the agonist, half a log unit apart, were selected from this range to generate a concentration-response curve. It was ensured that the maximum effective concentration of the agonist was used in each experiment. The first 2 stimulations (S1 and S2) were carried out in the absence of an agonist. The agonist was added to the perfusion fluid at a fixed time (2 min or 10 min) prior to each stimulation beginning with S3 and remained until the end of the stimulation. Agonist was added in the order of increasing concentrations from S3 to S9 and the facilitatory response at each concentration was measured to generate a concentration-facilitatory response curve. A single concentration-response curve was generated in each experiment.
When agonist concentration-facilitatory response curves were generated in the presence of various concentrations of an antagonist, an appropriate concentration of the antagonist was added to the perfusion fluid 45 min prior to SI and was perfused throughout the experiment. The agonist concentration-response curve was generated in the presence of the antagonist as described above.
Fitting of agonist concentration-response curve The concentration-response curve to an agonist was fitted to a logistic equation using a computer programme (Kaleidagraph, Abelbeck Software). The concentrations producing 50% of the maximum response (EC,0 values) were obtained directly from the equation. The logistic equation which was used to best fit the curves is as follows (Waud & Parker, 1971) :
Here, M = maximum response; [A] = molar agonist concentration; n = slope of the curve; EC50 = agonist concentration producing half the maximum response.
Determination of rank order ofpotency and potency ratio The rank order of potency and the potency ratios for P-adrenoceptor agonists relative to (-)-isoprenaline were determined. For the potency ratio, the EC50 value for the agonist was divided by the EC50 value for (-)-isoprenaline. Thus, any potency ratio greater than 1 indicates that the agonist is that many fold less potent than (-)-isoprenaline.
Determination of pA2 and pKb values In some cases when only one concentration of the antagonist was used, the pA2 value was calculated from the Furchgott equation (Furchgott, 1972) In other cases, Schild regression analysis was performed to determine the pKb values of the antagonists. This analysis is based upon following equation (Arunlakshana & Schild, 1959) : Once the criteria of similar maximum responses and parallelism of the agonist concentration-response curves in the absence and presence of the antagonist was satisfied (Kenakin, 1984) , Schild regression analysis was carried out. The concentration-ratio (shift) of the agonist concentrationresponse curve in the presence of a particular concentration of the antagonist as compared to that in the absence of the antagonist was calculated by dividing the ECGm value obtained in the presence of the antagonist by the EC50 value obtained in the absence of the antagonist. Then a Schild plot was obtained by plotting log molar concentrations of the antagonist on the abscissa scale and log (concentration ratio -1) on the ordinate scale. The data points were fitted by simple regression and the slope of the regression line was determined. If the slope was not significantly different from 1 then a line with the slope of 1 was best fitted to the points (MacKay, 1978) and was extrapolated to determine the x-intercept at y = 0. This x-intercept was accepted as the pKb value for the antagonist at the receptors.
Radio-ligand binding and autoradiography studies
Animal and tissue treatment Twenty male Wistar rats of 235-265 g were anaesthetized with pentobarbitone (60 mg kg-', i.p.) and the right renal artery was exposed. In 10 rats, the right kidney was denervated by stripping the right renal artery surgically and swabbing it with a 10% phenol solution dissolved in ethanol. Ten other rats were sham-operated. Animals were allowed to survive for one week after denervation and then were killed by pentobarbitone overdose. The right kidney was dissected out and washed with an ice-cold 0.9% NaCl solution to remove blood and cell debris. The upper half of the right kidney was weighed and used for NA assay. The lower half of the kidney was cut into 0.3 cm slices which were frozen in isopentane cooled with liquid nitrogen and used for P-adrenoceptor assay and autoradiography. Sections, 8 gm thick, were obtained with a -20'C microtome cryostat and mounted on pre-weighed gelatin-coated microscope slides.
NA assay The upper half of the right kidney was homogenized in ice-cold 0.1 M HC104 (5 ml gl tissue). The homogenate was centrifuged at 2000 g for 20 min in a refrigerated centrifuge and the resulting supernatant was used for NA assay. NA was assayed by h.p.l.c.-e.c. according to the procedure detailed elsewhere (Amenta et al., 1987 (Bilski et al., 1983; Engel et al., 1985) . The optimal binding time and temperature were determined in a series of preliminary experiments. Nonspecific binding was evaluated by incubating some sections in the presence of 1 gM (-)-propranolol. Furthermore, to assess the specificity of ['25I]-CYP binding to P-adrenoceptors, other sections were incubated in the presence of different concentrations of (-)-and (+)-propranolol, isoprenaline, NA and phentolamine.
After incubation, the sections were washed in cold buffer (2 times, 5 min each), rapidly rinsed in distilled water, wiped onto Whatman glass filters and placed in scintillation vials. Vials were then placed in a gamma counter (LKB, Bromma, Sweden) for radioactivity determination. Further details of the radio-ligand binding procedures are reported elsewhere (Amenta et al., 1991) .
Autoradiography For autoradiographic experiments, the sections were incubated according to the optimal binding parameters determined in preliminary experiments using a radio-ligand concentration of 0.4nM. Such a concentration produced the highest specific/nonspecific binding ratio, as determined in radio-ligand binding experiments (see results). The selective antagonists ICI 89,406 and ICI 118,551 were used at concentrations of 100 nM and 70 nM, respectively, on the basis of radio-ligand binding data. At the end of the incubation, the sections were washed as above, rinsed quickly in distilled water and air dried. Then they were post-fixed by exposure to formaldehyde vapours at 80GC for 30min and processed for autoradiography according to the method of Young & Kuhar (1979) . Briefly, coverslips coated with Ilford L4 nuclear emulsion (diluted 1:1 with distilled water) were attached to the slides; then they were exposed for 3-6 days in light-proof boxes, developed with Kodak D19, fixed with Agefix-Agfa, stained with toluidine blue and observed under a light microscope equipped with both bright-and dark-field condensers.
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The density of silver grains developed by autoradiography and representing ['25I]-CYP binding sites was assessed according to the procedure detailed in an earlier paper (Amenta et al., 1991) . Briefly, silver grains were counted in an area of 500 JAm2 as determined by an image analyzer connected via a TV camera to the microscope, using a final magnification at the camera of x 400. Counts were made by three investigators independently on at least 5 consecutive sections per kidney (n = 10, denervated or sham-operated).
Statistical evaluation
Fractional overflows of NA in different groups in the absence and presence of various antagonist concentrations but in the absence of agonist (at SI and S2) were compared by unpaired t-test or one factor analysis of variance. Maximum facilitation in different groups was compared by an unpaired t-test or one factor analysis of variance. To test parallelism of concentration-response curves, each average concentrationresponse curve was converted to a straight line by transforming the values of mean facilitatory response at each concentration into probits which were plotted on the ordinate scale against log molar concentration of the agonist on the abscissa scale. The slopes of the straight lines were then compared by analysis of covariance. The slope of the Schild regression plot was tested by t-test to determine whether it was significantly different from unity. In the radio-ligand binding and autoradiography studies, the densities of [1251]_ CYP binding among the various groups were compared by one factor analysis of variance (ANOVA). A significance level of P <0.05 was accepted.
Drugs and chemicals
Chemicals used in preparation of the Krebs bicarbonate solution and elsewhere were reagent or h.p.l.c. grade and obtained from standard sources. The following stock solutions were divided into aliquots and stored at -80°C. Solutions of (-)-isoprenaline (Sigma), (+)-isoprenaline (>99%, Sigma) and (-)-adrenaline (Sigma) were prepared in 0.01 N hydrochloric acid containing 1 mM sodium metabisulphite. The maximum facilitatory responses were 93 ± 6% and 107 ± 14% in the control and propranolol groups, respectively. The fractional overflows of noradrenaline (NA) in the absence of (-)-isoprenaline were 0.58 0.03% and 0.57 ± 0.06% while the renal NA contents were 495 83 and 435 ± 23 pmol g-' in control and propranolol groups, respectively. These experiments were performed in the presence of cocaine (10 9M) and corticosterone (40 9M) to inhibit neuronal and extraneuronal uptake, phentolamine (10 9M) to block prejunctional a-adrenoceptors, indomethacin (3 9M) to inhibit renal prostaglandin synthesis and captopril (0.1 9AM) to inhibit renal angiotensin II synthesis.
Solutions of dobutamine (Eli Lilly), procaterol (Sigma), metoprolol (Sigma) and ICI 118,551 (Imperial Chemical Industries) were prepared in distilled water. The following stock solutions were stored at 40C. A solution of indomethacin (Sigma) was prepared in ethanol. Solutions of cocaine (Sigma) and corticosterone (Sigma) were prepared in 0.01 N hydrochloric acid and 90% dimethylsulfoxide, respectively. All stock solutions were diluted with Krebs bicarbonate solution to the appropriate concentrations on the day of the experiment. A fresh stock solution of salbutamol (Sigma) was prepared daily and was diluted with Krebs bicarbonate solution to the appropriate concentrations. Captopril (Sigma) and phentolamine mesylate (Ciba-Geigy) were weighed daily, dissolved in distilled water and added to Krebs bicarbonate solution. ['25I]-cyanopindolol (specific activity 2,000 Ci mmol ') was purchased from the Radiochemical Centre of Amersham (Buckinghamshire, UK).
Results
Control experiments performed in the absence of an agonist demonstrated that S-I fractional overflow of NA was reproducible during the course of the experiment (data not shown). The P-adrenoceptor antagonists, when given alone, did not affect S-I fractional overflow of NA (data shown in legends to figures representing agonist concentration-response curves in the absence and presence of the antagonist).
Effects of the non-selective P-adrenoceptor agonist, isoprenaline, on neurotransmitter overflow Exposure of the kidney to the non-selective P-adrenoceptor agonist, (-)-isoprenaline, results in dose-dependent facilitation of S-I neurotransmitter overflow (Figure 1 ). The tissue was exposed to each agonist concentration for 2 min to avoid desensitization of prejunctional P-adrenoceptors (Lakhlani & Eikenburg, 1993) . The maximum facilitatory response was 93 ± 6% while the EC50 concentration was 1.2 nM (Figure 1 ).
The concentration-effect curve to (-)-isoprenaline was shifted 52 fold to the right in a parallel fashion by propranolol, the Pj-and P2-adrenoceptor antagonist, without significantly altering the maximum facilitatory response (107 ± 14%) (Figure 1 ). The pA2 for propranolol at prejunctional P-adrenoceptors, determined from the Furchgott equation (Furchgott, 1972) , was estimated to be 9.2.
The rank order ofpotency and the potency ratios of P-adrenoceptor agonists As a first step in identifying the P-adrenoceptor subtype responsible for the facilitatory effect on neurotransmitter overflow, the rank order of potency and the potency ratios of various 13-adrenoceptor agonists were determined. An agonist exposure time of 2 min was used. The observed rank order of potency was (-)-isoprenaline > procaterol > salbutamol > adrenaline > (+)-isoprenaline ( Figure 2a ). In addition, procaterol, salbutamol, adrenaline and (+ )-isoprenaline were observed to be 2-fold, 3-fold, 10-fold and 25-fold less potent than (-)-isoprenaline, respectively (Table 1) . It should be noted here that adrenaline, a mixed P-and a-adrenoceptor agonist, did not affect the perfusion pressure (data not shown), suggesting that a-adrenoceptor blockade by phentolamine remained effective in the presence of adrenaline.
In contrast to the agonists described above, dobutamine, the PI-adrenoceptor agonist, did not produce any effect on sympathetic neurotransmission in the rat kidney (Figure 2b) within the concentration range of 1 nM to 10 9AM. Dobutam- ine, also an a-adrenoceptor agonist at higher concentrations, did not influence perfusion pressure within this concentration-range, suggesting that a-adrenoceptor blockade by phentolamine remained effective. At the concentrations of 100 AM and 1 mM, dobutamine produced marked vasoconstriction, Figure 3a and Table 2 ). The curves were parallel and suggested a competitive antagonism by ICI 118,551 ( Figure  3a) . The slope of the regression line from the Schild plot was not significantly different from unity and when constrained to a slope of 1 the pKb value was determined to be 9.20 ( Figure  3b and Table 2 ). Similarly, ICI 118, produced parallel dextral shifts of the procaterol concentrationfacilitatory response curves. The maximum response to procaterol was not significantly affected by any concentration of ICI 118,551 ( Figure 3c and Table 2 ). When the Schild analysis was performed, the slope of the regression line was not significantly different from unity and when constrained to a slope of one the pKb value for ICI 118,551 against procaterol was determined to be 9.35 (Figure 3d) .
In a second series of experiments, the pKb of the selective P3-adrenoceptor antagonist, metoprolol, was determined with (-)-isoprenaline and procaterol. Metoprolol produced parallel dextral shifts of the isoprenaline concentration-facilitatory response curves without significantly affecting the maximum responses ( Figure 4a and Table 2 ). Schild analysis revealed that slope of the regression line was not significantly different from unity and when the plot was constrained to a slope of unity, the pKb value of metoprolol against (-)-isoprenaline was 6.25 ( Figure 4b and Table 2 ). Similarly, when the effects of ICI 118,551 on the procaterol concentration-facilitatory indicates that the agent is more potent than (-)-isoprenaline.
bPotency ratios of the agonists at prejunctional P-adrenoceptors were derived from the data presented in Figure 4a . CYabuuchi (1977) ; O'Donnell & Wanstall (1985) . Furchgott (1972) . 'Bowman & Rand (1982) .
,L. response curves were examined, ICI 118,551 produced parallel dextral shifts of the procaterol curves without significantly altering the maximum response ( Figure 4c and (Table 3 ).
Surgical denervation of the rat kidney resulted in a 44% reduction in the total 13-adrenoceptor density and an 80% reduction in the P2-adrenoceptor sites (Table 3) . In contrast, P3-adrenoceptors were not significantly affected.
Autoradiography
Silver grains developed by autoradiography and corresponding to [1251I]-CYP binding sites could be detected both in kidney cortex and outer medulla, as well as intraparenchymal renal blood vessels. The incubation in the presence of the two specific antagonists allowed for discrimination between the two P-adrenoceptor subtypes.
In cortical structures (glomeruli and renal tubules), PI- Surgical denervation had little effect on this pattern (data not shown). P2-Adrenoceptors also were present in the outer medulla, where they are most probably associated with collecting tubules (Figure 7 ). Intraparenchymal branches of the renal artery displayed silver grains in the adventitia and adventitial-medial border; these binding sites were displaced by ICI 118,551 and thus represent P2-adrenoceptors ( Figure   8 ). No silver grain was detectable in the arterial muscle layer (Figure 8 ). Importantly, surgical denervation resulted in a complete disappearance of this population, suggesting a prejunctional localization of these binding sites (Figure 8) (Furchgott, 1972) . Also, the receptor system should be functionally isolated and the receptor-mediated response should be minimally influenced by other endogenous or exogenous factors (Furchgott, 1972) . Hence, with regard to prejunctional P-adrenoceptors, the final determination of the potency ratio or pKb value may be influenced by (1) a co-transmitter released with NA (Bartfai et al., 1988) dFacilitation of stimulus-induced fractional neurotransmitter overflow expressed as a percentage of the overflow in the absence of agonist. The antagonists alone had no effect on overflow at the concentrations studied. (Rump, 1987) ; (3) active removal of NA or P-adrenoceptor agents, and (4) endogenous factors generated in the organ, especially angiotensin II and prostaglandins in the present case (Boke & Malik, 1983; Malik, 1988) . Therefore, care was taken in the present study to minimize the influence of these factors. First, it has been suggested that ATP plays the role of a sympathetic co-transmitter in the rat kidney which, however, has no effect on S-I overflow of NA (Schwartz & Malik, 1989) . Second, only prejunctional a-adrenoceptors are tonically active under the experimental conditions of the present study and influence of prejunctional a-adrenoceptors on sympathetic neurotransmission was minimized in the present study by using phentolamine. Third, active uptake of NA or P-adrenoceptor agents was prevented by inhibiting neuronal and extraneuronal uptake. Finally, synthesis of renal angiotensin II and prostaglandins was inhibited with captopril and indomethacin to eliminate their potential influence on P-adrenoceptor-mediated facilitation.
Another important point in the use of pharmacological methods for characterizing prejunctional P-adrenoceptors is the choice of P-adrenoceptor agents. O'Donnell & Wanstall (1979) pointed out that the pA2 values obtained with selective receptor agonists and antagonists provide the best basis for receptor differentiation. They demonstrated that the pA2 values for a selective antagonist may differ against agonists of different selectivities in tissues containing more than one receptor subtype. Hence, P-adrenoceptor agonists and antagonists with different selectivities for P-adrenoceptor subtypes were used in the present investigation to differentiate between the Pi-, P2-and P3-subtypes as prejunctional P-adrenoceptors.
One strategy which can provide evidence for the involvement of a particular receptor subtype in a functional response is examination of the rank order of potency and potency ratios of various P-adrenoceptor agonists (Kenakin, 1984) . In the present investigation, all the agonists, except dobutamine, acted as full agonists at prejunctional 0-adrenoceptors in the rat kidney. The rank order of potency of P-adrenoceptor agonists was, (-)-isoprenaline >procaterol >salbutamol >adrenaline >(+)-isoprenaline, which is indicative of the ,82-subtype since at the Pi-subtype, adrenaline is more potent than salbutamol and procaterol. This rank order of potency also confirmed the stereoselectivity of prejunctional P-adrenoceptors as (-)-isoprenaline was observed to be more potent at prejunctional 1-adrenoceptors than (+)-isoprenaline. Another important observation in the present investigation was that the potency ratios of the Padrenoceptor agonists are similar to their reported ratios at P2-adrenoceptors, and differ significantly from their reported ratios at PI-adrenoceptors (see Table 1 ). Thus, these results suggest that prejunctional 13-adrenoceptors are of the P2-subtype.
In contrast to the other P-adrenoceptor agonists used, the preferential P3-adrenoceptor agonist, dobutamine, did not produce any facilitation of S-I overflow of NA. This may be due to the presence of the P2-subtype as prejunctional Padrenoceptors. However, two alternative explanations should be considered. One possibility is that the concentrations of dobutamine used in the present study may not be sufficient to activate prejunctional P-adrenoceptors. Dobutamine is 200 to 1000 fold less potent than isoprenaline at the P-adrenoceptor subtypes (Wagner & Schumann, 1979; Kenakin, 1981) . Since the EC50 value for (-)-isoprenaline at prejunctional ,-adrenoceptors was observed to be 1-2 nM, dobutamine should produce facilitation in the concentration range of 1 to 10 pM which was examined in the present study. Thus, the concentrations of dobutamine studied were appropriate. Second, dobutamine can activate x-adrenoceptors in addition to its action at P-adrenoceptors (Ruffolo et al., 1981 Another strategy which was used in the present study to characterize the prejunctional P-adrenoceptor was the determination of antagonist pA2 or pKb values. Propranolol, the P-adrenoceptor antagonist, has high affinity (in nm range) for the if-and f2-subtypes, but low affinity (in IM range) for P3-adrenoceptors (Bond & Clark, 1988 :~. , : . i ; S . ; : . . . . . . . . . These results imply that the P3-adrenoceptor subtype does not significantly contribute to the facilitatory response in the rat kidney.
To differentiate between the PI-and P2-subtypes as prejunctional P-adrenoceptors, the pKb values for ICI 118,551 and metoprolol at prejunctional P-adrenoceptors also were determined. ICI 118,551 exhibits 100 to 300 fold selectivity for P2-adrenoceptors over PI-adrenoceptors (Bilski et al., 1983; Lemoine et al., 1985) . It has been suggested that ICI 118,551 may produce nonspecific inhibitory effects at 1 JiM or higher concentrations (Bilski et al., 1983 Donnell & Wanstall, 1979) . To determine exactly which subtype was involved in the facilitation, we compared the pKb of ICI 118,551 at prejunc-tional P-adrenoceptors with its reported pA2 at the classical P-adrenoceptor subtypes. The pA2 of ICI 118,551 in guineapig atria (PI-adrenoceptors) has been reported to be 6.96 (O'Donnell & Wanstall, 1980) and 7.17 (Bilski et al., 1983) . Alternatively, the pA2 of ICI 118,551 in guinea-pig trachea (P2-adrenoceptors) has been reported to be 8.69 (O'Donnell & Wanstall, 1980) , while at P3-adrenoceptors, it is 5.49 and 5.33 (Hollenga & Zaagsma, 1989) . Thus, the pA2 of ICI 118,551 at prejunctional P-adrenoceptors is similar to its pA2 at P2-adrenoceptors, implying that a homogeneous population of P2-adrenoceptors may mediate the facilitation. However, a possibility of a small contribution by P1-adrenoceptors cannot be eliminated on the basis of these results, as a narrow concentration-range of ICI 118,551 was used in the present study within which a P3-adrenoceptor contribution may not have been apparent (Lemoine & Kaumann, 1983 ). This possibility was evaluated by determining the pKb values of the selective P1-adrenoceptor antagonist, metoprolol.
Metoprolol has approximately 30 fold selectivity for PIadrenoceptors as compared to P2-adrenoceptors (Toda et al., 1978; Wahlund et al., 1990) . It has been demonstrated that metoprolol may exhibit a local anaesthetic-like effect at 1 AM or higher concentrations (Doggrell, 1988) . However, metopolol did not affect sympathetic neurotransmission at the concentrations used implying that it did not produce any nonspecific effect. Similar to ICI 118,551, the slopes of the Schild regression lines for metoprolol were not significantly different from unity. Furthermore, the pKb values for metoprolol against (-)-isoprenaline and procaterol at prejunctional P-adrenoceptors were 6.25 and 6.18, respectively, suggesting that its antagonism was at a single site. These values are similar to the pA2 of metoprolol in guinea-pig trachea (representing its antagonism at P2-adrenoceptors) which are 6.06 (Harms, 1976) and 6.25 (Toda et al., 1978) , but different from its pA2 in guinea-pig atria, representing its antagonism at P1-adrenoceptors, which are 7.43 (Harms, 1976) and 7.93 (Toda et al., 1978) . Together these results refute the involvement of PI-adrenoceptors in facilitation of S-I overflow of NA in the rat kidney and support the notion of a homogeneous population of P2-adrenoceptors mediating the response. The next question is: where are these receptors located?
Although traditionally it is believed that prejunctional Padrenoceptors are located on sympathetic nerve terminals, very sparse anatomical evidence has been obtained to support this concept (Sharma & Banerjee, 1978; Dahlof et al., 1986) . Theoretically, if these receptors are located prejunctionally, then destruction of the sympathetic nerve terminals containing these receptors should result in loss of the receptors. We utilized this theoretical concept to examine the location (prejunctional or postjunctional) of 'prejunctional' P-adrenoceptors in the rat kidney using radio-ligand binding and autoradiography combined with surgical denervation.
The binding of ['251 ]-CYP in the rat kidney slices was saturable and of high affinity. Furthermore, the affinity of ['251 ]-CYP for renal P-adrenoceptors observed in the present investigation is similar to that reported in previous studies with the same radio-ligand in the rat kidney (Munzel et al., 1984; Summers et al., 1985) . The binding studies revealed that of the total P-adrenoceptor population in the rat kidney, PI-adrenoceptors were 63% while P2-adrenoceptors were 37%. Other investigators also have reported similar values for renal P-adrenoceptor subtypes (Snavely et al., 1982; Summers et al., 1985) . However, a more important observation was that surgical denervation, accompanied by more than 90% reduction in renal NA content, resulted in 80% reduction in the P2-adrenoceptors. Disappearance of the p2-sites upon surgical denervation suggests a prejunctional location for these receptors. This result is in strong agreement with the results obtained by pharmacological methods which also demonstrated that prejunctional P-adrenoceptors are of the P2-subtype. In contrast to P2-adrenoceptors, the Pjadrenoceptor population was not significantly affected by surgical denervation. This suggests that P1-adrenoceptors are not present on sympathetic nerve terminals. This suggestion is supported by the pharmacological demonstration that ,-adrenoceptors are not involved in facilitation of S-I overflow of NA in the rat kidney. The results obtained in the present study are at variance with those by Fortin & Sundaresan (1987) and Woodcock et al. (1985) who failed to observe any effect of sympathectomy on P-adrenoceptor population in the rat kidney. However, Fortin & Sundaresan (1989) used only the renal cortex to examine the P-adrenoceptor population in that study, in contrast to the whole kidney preparation used in the present study, and this may account for the different results. On the other hand, Woodcock et al. (1985) failed to observe the effect of chemical sympathectomy on P-adrenoceptors in the whole kidney. The reason for the discrepancy between this and our results is not known.
The prejunctional localization of prejunctional P-adrenoceptors also was confirmed in the present investigation by use of autoradiography. Autoradiographic analysis of renal Padrenoceptors demonstrated that P-adrenoceptors were localized in cortex and outer medulla. Cortical ,-adrenoceptors, associated with glomeruli and tubules, were mainly P in nature with a small population of P2-adrenoceptors present on the tubules. In contrast, collecting tubules present in outer medulla mainly contained P2-adrenoceptors. These localizations of renal P-adrenoceptors are in general agreement with other reports (Summers & Kuhar, 1983; Summers et al., 1985; Healy et al., 1985) . Surgical denervation did not alter the density of P-adrenoceptor subtypes present at cortical and outer medullary locations, implying that these receptors are not associated with renal sympathetic nerves innervating these structures (Barajas & Powers, 1990 ). An important observation was the presence of P2-adrenoceptors on the adventitia and adventitial-medial border of the intraparenchymal branches of the renal artery. P2-Adrenoceptors on the renal vasculature also have been reported by Summers et al. (1985) . It has been demonstrated previously that the intraparenchymal branches are innervated by sympathetic nerves (Barajas & Powers, 1990) . Since the adventitia and adventitial-medial border of an artery represent the vascular zones where sympathetic nerve plexus ends (cf. Amenta et al., 1991) , P2-adrenoceptors associated with the intraparenchymal branches of the renal artery may represent prejunctional P2-adrenoceptors located on renal sympathetic nerve terminals. The conclusive evidence for this hypothesis was obtained when it was observed that this population of P2-adrenoceptors disappeared following destruction of the nerve terminals by surgical denervation. Thus, these results provide the direct anatomical evidence for the presence of P2-adrenoceptors on the renal sympathetic nerve terminals associated with renal vasculature. Furthermore, these results suggest that prejunctional P-adrenoceptors in the rat kidney may not affect tubular function directly. Instead, they may influence renal function by altering renal hemodynamics.
In summary, the present study demonstrates that renal prejunctional ,-adrenoceptors are of the p2-subtype in nature.
Anatomical evidence was obtained suggesting that these receptors are located on sympathetic nerve terminals associated with the renal vasculature rather than renal tubules. Thus, prejunctional P2-adrenoceptors in the rat kidney may influence renal function by altering sympathetic neurotransmission at the renal vasculature level. 
